arrow
A

Alfred H.J. Kim

harvard university medical affiliates
H指数:35
被引数:5,657

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prospective SARS-CoV-2 additional vaccination in immunosuppressanttreated individuals with autoimmune diseases in a randomized controlled trial

在随机对照试验中,免疫抑制治疗的自身免疫性疾病患者中SARS-CoV-2加强疫苗接种的前瞻性研究

2026-01-090
OA
Patient outcomes from implementing a shared decision-making aid for systemic lupus erythematosus: a prospective implementation study

系统性红斑狼疮患者实施共享决策辅助工具后的结局:一项前瞻性实施研究

2025-09-170
PRE
Implementation outcomes of a patient decision-aid in a diverse population with systemic lupus erythematosus in 15 US rheumatology clinics

系统性红斑狼疮患者决策辅助工具在15家美国风湿病诊所的多元人群中的实施结果

2025-06-012
PRE
Screening for Social Determinants of Health in Patients with Systemic Lupus Erythematosus: A Point-of-Care Feasibility Study

系统性红斑狼疮患者社会决定性健康因素的筛查:一项床旁可行性研究

2025-05-190
PREAI
Efficacy and safety of sipavibart for prevention of COVID-19 in individuals who are immunocompromised (SUPERNOVA): a randomised, controlled, double-blind, phase 3 trial

西帕韦伯特(sipavibart)预防免疫低下人群COVID-19的疗效与安全性(SUPERNOVA):一项随机、对照、双盲、III期试验

2025-02-010
PRE
Sleep Disturbance and SARS-CoV-2 Vaccinations in Patients With Chronic Inflammatory Disease
2023-02-131
OA
Reactogenicity of the Messenger RNA SARS-CoV-2 Vaccines Associated With Immunogenicity in Patients With Autoimmune and Inflammatory Disease
2022-08-155
OA
COVID-19 vaccine perceptions and uptake: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey

新型冠状病毒肺炎疫苗的认知和摄取: 新型冠状病毒肺炎全球风湿病学联盟疫苗调查的结果

2022-04-0133
OAAI
SARS-CoV-2 Infection and COVID-19 Outcomes in Rheumatic Diseases: A Systematic Literature Review and Meta-analysis

风湿性疾病的SARS-CoV-2感染和新型冠状病毒肺炎结局: 系统文献回顾和荟萃分析

2022-03-28127
OAAI